As of 2025-10-14, the Relative Valuation of Meridian Bioscience Inc (VIVO) is 32.57 USD. This relative valuation is based on P/E multiples. With the latest stock price at 33.97 USD, the upside of Meridian Bioscience Inc based on Relative Valuation is -4.1%.
The range of the Relative Valuation is 25.49 - 33.42 USD.
Range | Selected | |
Trailing P/E multiples | 26.4x - 34.6x | 33.8x |
Forward P/E multiples | 24.4x - 29.2x | 28.4x |
Fair Price | 25.49 - 33.42 | 32.57 |
Upside | -25.0% - -1.6% | -4.1% |
Date | P/E |